
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ligustrazine Suppresses Platelet-Derived Growth Factor-BB-Induced Pulmonary Artery Smooth Muscle Cell Proliferation and Inflammation by Regulating the PI3K/AKT Signaling Pathway
Huiping Huang, Lingjin Kong, Shaohua Luan, et al.
The American Journal of Chinese Medicine (2021) Vol. 49, Iss. 02, pp. 437-459
Closed Access | Times Cited: 18
Huiping Huang, Lingjin Kong, Shaohua Luan, et al.
The American Journal of Chinese Medicine (2021) Vol. 49, Iss. 02, pp. 437-459
Closed Access | Times Cited: 18
Showing 18 citing articles:
Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis
Tingting Liu, Rui Li, Huo Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 120
Tingting Liu, Rui Li, Huo Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 120
Halofuginone prevents inflammation and proliferation of high-altitude pulmonary hypertension by inhibiting the TGF-β1/Smad signaling pathway
Jiangtao Wang, Lina Guan, Jian Yu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Jiangtao Wang, Lina Guan, Jian Yu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
A New Therapeutic Trend: Natural Medicine for Ameliorating Ischemic Stroke via PI3K/Akt Signaling Pathway
Xian Liu, Xin-Yu Xiao, Xue Han, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7963-7963
Open Access | Times Cited: 25
Xian Liu, Xin-Yu Xiao, Xue Han, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7963-7963
Open Access | Times Cited: 25
Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension
Zhifeng Xue, Yixuan Li, Mengen Zhou, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 29
Zhifeng Xue, Yixuan Li, Mengen Zhou, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 29
Ligustrazine alleviates psoriasis-like inflammation through inhibiting TRAF6/c-JUN/NFκB signaling pathway in keratinocyte
Rundong Jiang, Jiaqi Xu, Yuezhong Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113010-113010
Open Access | Times Cited: 22
Rundong Jiang, Jiaqi Xu, Yuezhong Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 113010-113010
Open Access | Times Cited: 22
Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension
Xiuli Yang, Yang Yang, Ke Liu, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e14916-e14916
Open Access | Times Cited: 7
Xiuli Yang, Yang Yang, Ke Liu, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e14916-e14916
Open Access | Times Cited: 7
A modified Fangji Huangqi decoction ameliorates pulmonary artery hypertension via phosphatidylinositide 3-kinases/protein kinase B-mediated regulation of proliferation and apoptosis of smooth muscle cells in vitro and in vivo
Zhifeng Xue, Mengen Zhou, Yiman Liu, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116544-116544
Closed Access | Times Cited: 7
Zhifeng Xue, Mengen Zhou, Yiman Liu, et al.
Journal of Ethnopharmacology (2023) Vol. 314, pp. 116544-116544
Closed Access | Times Cited: 7
The role and mechanism of thrombospondin-4 in pulmonary arterial hypertension associated with congenital heart disease
Haowei Zeng, Di Lan, Bingyi Li, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Haowei Zeng, Di Lan, Bingyi Li, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Natural Products for the Treatment of Pulmonary Hypertension: Mechanism, Progress, and Future Opportunities
Zuomei Zeng, Xinyue Wang, Lidan Cui, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 3, pp. 2351-2371
Open Access | Times Cited: 4
Zuomei Zeng, Xinyue Wang, Lidan Cui, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 3, pp. 2351-2371
Open Access | Times Cited: 4
MicroRNA miR-627-5p restrains pulmonary artery smooth muscle cell dysfunction by targeting MAP 2 K4 and PI3K/AKT signaling
Ting Li, Xiaoqin Tan, Yuexia Huang, et al.
Genes and Environment (2022) Vol. 44, Iss. 1
Open Access | Times Cited: 7
Ting Li, Xiaoqin Tan, Yuexia Huang, et al.
Genes and Environment (2022) Vol. 44, Iss. 1
Open Access | Times Cited: 7
Molecular Mechanism Underlying Role of the XBP1s in Cardiovascular Diseases
Shu Liu, Hong Ding, Yongnan Li, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 12, pp. 459-459
Open Access | Times Cited: 7
Shu Liu, Hong Ding, Yongnan Li, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 12, pp. 459-459
Open Access | Times Cited: 7
Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension
Jingjing Zhou, Furong Li, Yicheng Yang
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Jingjing Zhou, Furong Li, Yicheng Yang
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Ligustrazine protects against chronic hypertensive glaucoma in rats by inhibiting autophagy via the PI3K-Akt/mTOR pathway.
Hongyan Du, Rong Wang, Jian‐Liang Li, et al.
PubMed (2021) Vol. 27, pp. 725-733
Closed Access | Times Cited: 7
Hongyan Du, Rong Wang, Jian‐Liang Li, et al.
PubMed (2021) Vol. 27, pp. 725-733
Closed Access | Times Cited: 7
Ethyl pyruvate alleviates pulmonary arterial hypertension via PI3K-Akt signaling
Xin Lv, Jianhua Li, Ruyuan Wei, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access
Xin Lv, Jianhua Li, Ruyuan Wei, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access
Assessing causal associations of blood counts and biochemical indicators with pulmonary arterial hypertension: a Mendelian randomization study and results from national health and nutrition examination survey 2003–2018
Zhekang Liu, Qingan Fu, Qingyun Yu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Zhekang Liu, Qingan Fu, Qingyun Yu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
The efficacy and safety of herbal formulas for adults with pulmonary hypertension combined with chronic obstructive pulmonary disease: a systematic review and meta-analysis involving 1,865 participants
Rui Liang, Cheng‐Di Dong, Haobo Li, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 9, pp. 5923-5935
Open Access
Rui Liang, Cheng‐Di Dong, Haobo Li, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 9, pp. 5923-5935
Open Access
Potential analgesic effect of Foshousan oil-loaded chitosan-alginate nanoparticles on the treatment of migraine
Yulong Chen, Qingzhou Cheng, Shan Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
Yulong Chen, Qingzhou Cheng, Shan Zeng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
Differentially Expressed Genes and Pathways between Reversible and Irreversible Pulmonary Arterial Hypertension Associated with Congenital Heart Disease Investigated by Bioinformatics Analysis in Rat Model
Haowei Zeng, Di Lan, Xiaoqin Liu, et al.
Research Square (Research Square) (2023)
Open Access
Haowei Zeng, Di Lan, Xiaoqin Liu, et al.
Research Square (Research Square) (2023)
Open Access